spacer
home > ict > winter 2009 > from dumb to smart
PUBLICATIONS
International Clinical Trials

From Dumb to Smart

BACKGROUND

The business fundamentals of conducting clinical research have changed dramatically over the last few years. Although not quite as well-publicised as the recent events in world financial markets, the fundamentals of the industry have steadily eroded. Clinical trials are more expensive, take longer to run, and patient recruitment is harder than ever, to give just a few examples.

Even more worrying is the fact that the industry has been content to operate in the dark, with few objective metrics about the convoluted internal operations critical to planning and conducting clinical trials. For example, the Six Sigma methodologies that can be applied to the clinical development process have only recently been recognised by the industry, despite the fact that Six Sigma provides objective criteria that helps to measure the value of decisions. These decisions commit hundreds of millions of dollars to development programmes.

Furthermore, job cuts are occurring with increasing regularity, as are dramatic outsourcing arrangements and billion-dollar acquisitions. Unfortunately, while these big announcements garner a lot of attention, the actions often obscure the need to improve the efficiency and effectiveness of day-to-day clinical operations. In fact, the decisions related to crucial development activities that determine the successes of specific clinical programmes and the overall health of the industry are often overlooked.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Edward Seguine is General Manager, Trial Planning Solutions, at Medidata Solutions, and is responsible for strategy development and execution. As a member of the senior management team at Medidata, Ed oversees all development, implementation and commercialisation activities for Medidata CRO Contractor, Medidata Designer, Medidata Grants Manager and the proprietary benchmark data these products rely on. Previously, Ed served as CEO of Fast Track Systems Inc, after moving from Eli Lilly, where he was instrumental in establishing both e.Lilly and Lilly Ventures. Ed is active in CDISC as the chair-elect of the Industry Advisory Board, a non-voting member of the CDISC board, and Financial Oversight Committee. In addition, he has written several articles and is a periodic speaker at industry events. Ed earned his BBA from Brigham Young University and MBA from Indiana University.
spacer
Edward Seguine
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

TrialScope Announces Partnership with Greater Gift

JERSEY CITY, NJ May 14, 2019 TrialScope, the global leader in clinical trial transparency, disclosure compliance and patient engagement solutions, has partnered with Greater Gift to donate vaccines to children in need.
More info >>

White Papers

Sterile Vials Made of Tubular Glass

Gerresheimer AG

Gx RTF vials powered by Ompi EZ-fill enhance flexibility by facilitating packaging needs from clinical stage to industrialization with the common goal to minimize customer product risks and optimize total cost of ownership. Gerresheimer combines the competencies in converting glass tubes to serum/ injection vials and ready-to-fill processing for our pharma and biotech customers.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement